Crises Management and Resilience
Enables immediate use of blood products or medicine during crisis and disaster events
​
Tridentify
QTA Tracer System® - Enables immediate use of blood products or medicine during crisis and disaster events
A changing world requires both civil-military cooperation and stockpiles of primarily Whole Blood, Plasma and Medicines for mass casualty management and life-saving intervention. A mass casualty incident (MCI) may be defined as a disastrous event, such as hurricanes, major explosions, car accidents, train derailment, terrorist attacks or armed conflicts, where the number and type of injuries overwhelm the healthcare system.
​​​​​​
According to NATO, (Non-binding guidelines, February 1999), one may reduce mortalities by transfusing Whole Blood (WB) at the Point-of-Injury (POI). The WB has cold platelets and thus maintains clot strength to stop massive bleeding.
​
QTA Tracer System® eliminates uncertainties during mass casualty management*
-
Secures full visibility and temperature monitoring across the medical cold chain, supporting healthcare resilience in any situation
-
Ensuring temperature control and quality of blood, medicines and biological products​​
-
​Enhance traceability, compliance, and interoperability
-
Supporting National readiness and Defense resilience
​
* QTA Tracer 2.0 is CE-marked as a Medical Device according to MDD class IIa and certified according to ISO 13485:2016
QTA Tracer BIO is CE-marked FCC (CFR Title 47 Part 15 subpart B, Class B), RED, RTCA/DO160G Section 21, non-medical device and certified according to ISO 9001:2015
​​
The Operational challenge for NATO -
Ensuring immediate use of safe whole blood
in every environment
-
NATO is reintroducing Low-Titer O Whole Blood (LTOWB) to save lives in combat
-
Whole blood offers superior survival but is highly temperature-sensitive
-
In forward military and civil areas (Role 2/P2)
-
Cold chain interruptions are common
-
No network or power is guaranteed
-
Manual checks increase risk and waste
-
Result: Unnecessary blood disposal/waste or use of degraded units
​
The Tridentify Solution - QTA Tracer 2.0*
-
Medically certified MDD class IIa (MDR 2026) and ISO 13485 system for real-time blood shelf-life monitoring
-
Each QTA Tracer attaches directly to a blood bag
-
IP 67 - Robust, water immersion up to 1 m for 30 min
-
Calculates biological usability using time, temperature, and degradation algorithms (patented Shelf-Life Management)
-
Built-in LED light signal, green or red, shows if blood is safe (blinking feature for people with colour vision deficiencies) - No network required
-
Reliable data transfer when communication is available
Operational Benefits - Capability field values
-
Network-independent - also works in austere or disconnected environments
-
Instant visual indicator - enables immediate Go/No-go decisions
-
Dramatically reduces wastage - extends effective blood availability
-
Supports LTOWB, plasma & platelets - full spectrum battlefield use
-
Prepared to comply with STANAG 2136 / 3204 - for NATO deployment
Use Cases - Role 2 surgical units and mobile medical teams
-
Forward blood supply logistics (between base and field units)
-
MEDEVAC/CASEVAC transport (air, land, sea)
-
Special Forces and rapid response units
Strategic Impact
-
Tridentify bridges advanced medical monitoring and front-line reality
-
Enabling verified, safe, and mission-ready blood — anywhere, anytime
* QTA Tracer 2.0 is CE-marked as a Medical Device according to MDD class IIa and certified according to ISO 13485:2016